Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Amortizatization of Intangibles (2020 - 2025)

Arcutis Biotherapeutics (ARQT) has 6 years of Amortizatization of Intangibles data on record, last reported at -$2.0 million in Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 283.39% year-over-year to -$2.0 million; the TTM value through Dec 2025 reached $2.1 million, down 69.66%, while the annual FY2025 figure was $2.1 million, 69.66% down from the prior year.
  • Amortizatization of Intangibles reached -$2.0 million in Q4 2025 per ARQT's latest filing, down from $562000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $188.0 million in Q2 2023 and bottomed at -$3.7 million in Q3 2023.
  • Average Amortizatization of Intangibles over 5 years is $9.6 million, with a median of $290500.0 recorded in 2023.
  • Peak YoY movement for Amortizatization of Intangibles: crashed 2736.64% in 2021, then soared 69217.65% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$3.5 million in 2021, then surged by 158.37% to $2.0 million in 2022, then plummeted by 75.99% to $484000.0 in 2023, then surged by 126.45% to $1.1 million in 2024, then tumbled by 283.39% to -$2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were -$2.0 million in Q4 2025, $562000.0 in Q3 2025, and $2.7 million in Q2 2025.